Evidence of how cost-effectiveness (CE) of an HIV/AIDS intervention compares in a rural context and an urban context is deficient yet crucial to potential efficiency in resource allocations in South Africa. To inform policy makers about such potential, the CE of major HIV/AIDS interventions is estimated in these contexts over the period 2007-2020 Two versions of Spectrum Policy Modeling System (SPMS) are constructed; one for a rural context and another for an urban context. Then each version is populated with context-specific parameters, before being used to project the annual number of patients and health outcomes of an HIV/AIDS intervention and a related USUAL CARE. The cost evidence for an HIV/AIDS intervention and related USUAL CARE is applied to projected number of patients and the incremental CE ratio (ICER) of an HIV/AIDS intervention relative to USUAL CARE in each context is estimated. The ICERs in the two contexts for the same HIV/AIDS intervention are then used to compare the CE of that HIV/AIDS intervention across contexts. The paper finds that CE estimates of an HIV/AIDS intervention across a rural context and an urban context differ and the extent of that difference varies across HIV/AIDS interventions. Therefore, policy makers can increase efficiency by allocating resources in HIV/AIDS interventions in socio-economic contexts according to CE variations in such contexts.
Introduction
Despite a significant increase in resources committed to HIV/AIDS interventions by the South African government since 2007 (Govender, 2009) , the impact of the epidemic remains high. Therefore, efficient ways of allocating resources to maximise health benefits are needed. With the evidence that the effectiveness (Grassly et al., 2001; Wegbreit et al., 2006) and, by implication, the cost of HIV/AIDS interventions depend on socio-economic contexts, the on-going question remains: Do the cost and effectiveness of an HIV/AIDS intervention depend on whether the intervention is implemented in a rural area/context or an urban area/context? For if such dependence exists, South African policy makers would allocate resources to HIV/AIDS interventions according to how they are cost-effective in a rural context and an urban context, but this evidence has not been sufficiently produced. Therefore, this paper aims to provide such estimates, through modeling. (Govender, 2009 ). In the same year, he launched HIV counseling and testing (HCT) campaign targeting 15 million people (about one third of the population), by June 2010 (Cullinan and Bodibe, 2010) . By the time of this announcement, about seven million people were testing for HIV annually and 923 000 were receiving treatment (Department of Health, 2010:15) . In 2011, the government adopted early treatment policies which consisted of starting the provision of HAART therapy on patients when their CD4 count reached a threshold of 350. Implemented officially in April 2013 (Department of Health, 2013) , this policy, replaced the late treatment policy according to which patients started antiretroviral when their CD4 count reached a threshold of 200. In the same year, universal HIV/AIDS coverage for adult patients was adopted. This consisted of providing HAART therapy to any patient who needs it according to the early treatment guidelines. On AIDS day in December 2012, the Deputy President of the country announced that about 1.9 million patients were on antiretrovirals (Xinhua, 2012) . On the resources front, the HIV/AIDS budget in 2010 increased by 33% over the previous year, and in 2011, it increased further by 30% (Motsoaledi, 2011).
These commitments have started paying off in terms of the reduction of the impact of HIV/AIDS. For instance, some studies reported that survival among HIV/AIDS patients increased, following the speed of scaling up of antiretroviral therapy (Walensky et al., 2008) . Other evidence revealed a decrease in secondary infections as a result of the widespread rollout of antiretroviral drugs, which decreased viral loads in the infected population (Williams et al., 2011 , Department of Health 2011 . The rate of transmission from mother-to-child decreased from 8% in 2008 to below 4% in 2011 (Leach-Lemens, 2011). Furthermore, life expectancy increased from 56 years in 2008 to 60 years in 2011 (Xinhua, 2012) . These benefits are not only limited to health outcomes but to broader socio-economic benefits, given the link between health status and socio-economic life.
Though South Africa has recently seen a decrease in the impact of HIV/AIDS, the scale of the epidemic remains significant. The significance of the epidemic can be highlighted by reporting the most recent statistics. For example, projections of Actuarial Society of South Africa (2011) for 2012 indicate that there would be about 220,000 AIDS-related deaths, 110,000 new infections and 5,685,424 people living with HIV or AIDS. The importance of the epidemic implies that available resources are managed efficiently in order achieve the maximum health benefits with available resources. One way to efficiently manage resources in respect of their allocation to rural and urban contexts is to examine the cost-effectiveness of various HIV/AIDS interventions in these contexts.
The allocation of resources in a rural or an urban context based on the efficiency of an HIV/AIDS intervention in each context requires, however, estimates of the cost-effectiveness of such intervention to guide resources allocation. Determining these estimates is not straightforward though because of the uncertainty with which the interaction between an HIV/AIDS intervention and the context of its implementation influence the CE of that intervention.
The theory of the socio-economic determinants of health proposes that the impact of HIV/AIDS is lower in a context with higher socio-economic status (Marmot & Wilkinson, 2005) , for example, an urban context. The theory predicts that factors prevailing in a higher socioeconomic status, such as high levels of income, education, are conducive to favorable health conditions and avoidance of risky behaviour. This prediction implies that the impact of HIV/AIDS is higher in a rural context than in an urban context. Further implications of the theory are that the effectiveness of an HIV/AIDS intervention is lower in a rural context than it is in an urban context, based on the understanding that the effectiveness of an HIV/AIDS intervention is measured according to the extent to which it reduces the impact of HIV/AIDS.
The difference in the impact of HIV/AIDS across a rural context and an urban context, as a result of interaction between the intervention and the context, implies a difference in costs. The difference in the cost of an HIV/AIDS intervention in a rural context and an urban context can be grasped through the realization that an HIV/AIDS intervention earmarks specific activities related to the impact. For example, specific procedures are earmarked to patients whose CD4 count has reached a critical stage, while particular procedures are planned for patients with mild conditions. Since these HIV/AIDS impacts are caused by or originate from contextual factors, they prevail to a different extent in a rural and an urban context. Consequently, since these health impacts influence the activities of an HIV/AIDS intervention, and since they may prevail to a different extent in a rural and an urban context, they may lead to differences in the cost of an HIV/AIDS intervention in the two contexts. According to the 3 theory of the socio-economic determinants of health, a rural context is expected to be more impacted by the consequences of HIV/AIDS, such as new infections, AIDS sicknesses and AIDS-related deaths, than does an urban context. It is to be noted, however, that the prediction of the theory of socio-economic determinants of health may not be always valid. In fact the theory prediction is founded on the assumption that contextual factors in a given context influence on average individual behaviours and attitudes towards HIV/AIDS intervention in a similar manner. Other theories, however, indicate that there are individual-specific factors which guide risky behaviours and attitudes towards interventions. Psychosocial theories, for example, explain that risk behaviours or attitudes towards HIV/AIDS interventions depend on the ability and willingness to learn about change in such behaviours or attitudes (Rosenstock, 1974; Fishbein & Ajzen, 1975; Ajzen, 1991) . Economic theory explains that unsafe risk behaviour (sexual behaviour/attitude towards health interventions) is based on a cost and utility analysis between sexual partners, or a cost and utility analysis of patients with respect to using a specific HIV/AIDS intervention (Becker, 1976; Phillipson & Posner, 1993; Levy, 2002; Oster, 2007; Bhattacharya et al. 2007) . Epidemiological theories focus less on individual behaviours, but on epidemic behaviour, thus highlighting the fact that the risk of infections and the effectiveness of interventions depend largely on HIV prevalence within particular contexts (Geoffard & Phillipson, 1996) .
The possibility that all these individual and contextual factors prevail to a different extent and patterns in a rural context and an urban context, implies uncertainty in the CE of an HIV/AIDS intervention in these contexts. The uncertainty in CE estimates arises because of complex interactions between factors in a context and an HIV/AIDS intervention in that context. These interactions eventually lead to potential difference in CE estimates for rural and urban contexts which in turn presents opportunities for efficiency in resource allocations.
Despite the potential to increase efficiency by allocating resources according to CE estimates in rural and urban contexts in South Africa, such estimates have not been produced for major HIV/AIDS interventions in the country. The estimation of CE of an HIV/AIDS intervention in different contexts would require a follow up of patients in each context which is costly and can only provide CE estimates up to the point of follow up. Policy makers, however, need to plan for the future. Consequently, this paper models the CE and compares CE estimates across a rural context and an urban context for major HIV/AIDS interventions in South Africa, notably prevention of mother-to-child transmission (PMTCT), HAART FOR ADULTS and HAART FOR CHILDREN.
Methods
Two versions of Spectrum Policy Modeling System (Stover, 2011) are constructed, one for a rural context and another for an urban context. Each version is then used to make projections of the number of patients and health outcomes which in turn form the basis for the estimation of CE of HIV/AIDS interventions of interest in this paper and their related USUAL CARE. Spectrum Policy Modeling System (SPMS) was developed by Stover (2004) and is updated every two years to account for new developments in the sector of HIV/AIDS. The Spectrum Policy Modeling System (SPMS) is a modular programme which integrates many models from which researchers can activate those relevant to their research questions. The SPMS has been extensively used to inform policy on many aspects at national levels (Rehle & Shisana, 2002 , Wood et al., 2000 , sub-national level (Mekonnen et al., 2002) and international level (Anema et al., 2011) .
The construction of SPMS in each context consists of feeding SPMS with parameters and assumptions specific to that context. To this end, after deactivating unneeded models in the SPMS, the paper retains the demographic model and the AIDS impact model (AIM) and collects relevant parameters for these models in each context. Demographic parameters such as the distribution of the population per age and gender, trends in life expectancy, age distribution of fertility, total fertility, and migration assumptions used in these models Regarding the effectiveness of HIV/AIDS interventions, the transmission rate from mother-to-child in the absence of PMTCT is assumed to be 32.8% in a rural context and 30% in an urban context, based on the evidence regarding PMTCT transmission in developing countries and the differences in risk of transmission from mother to child in a rural context and an urban context , the infection rate under PMTCT is assumed to be 3.82% in a rural context and 3.5% in an urban context. For HAART interventions, the median time from infection to death in the absence of an HIV/AIDS intervention is set at 12.7 years for adults in a rural context and 11 years in an urban context, again an assumption drawn from the Department of Health (2003:93) and Stover (2004) . The annual survival rate on ART is assumed to be 85% and 90% for adults in a rural context and an urban context respectively and 80% and 85% for children in a rural context and an urban context (Stover, 2009 ). These are but a few key parameters used and some default parameters for South Africa used by the model builder are retained in the analysis. Table  1 below provides a summary of the key demographic and the impact of AIDS parameters and assumptions used in the model.
As would be expected, a high level of uncertainty is likely and as a result, before using the model projections for CE estimates in a rural context and an urban context, calibration is done. Specifically, the paper compares the sum of population data modeled by the paper in a rural context and in urban context, to the South African population data modeled by ASSA2008 AIDS model (Actuarial Society of South Africa, 2011). The paper compares also the sum of HIV prevalence data modeled by the paper in a rural context and in an urban context, to the South African prevalence data modeled by ASSA2008 AIDS model (Actuarial Society of South Africa, 2011). Data modeled by this paper compares favorably with data modeled by ASSA2008 AIDS models as shown in Figure 1 and therefore can be used to model cost-effectiveness.
To this end, the number of patients in each HIV/AIDS intervention and related USUAL CARE as well as the number of health outcomes for each HIV/AIDS intervention is projected over the period 2007-2020. The annual number of patients using an HIV/AIDS intervention is assumed to be the same as the number of patients using USUAL CARE. This assumption is based on the fact that patients indeed would seek usual health care in the absence of an HIV/AIDS intervention.
To the annual number of patients, the evidence on annual average costs of an HIV/AIDS intervention and USUAL CARE in a given context is applied to provide annual costs of HIV/AIDS interventions. These annual costs are summed up over the period 2007-2020 to provide the total costs of an HIV/AIDS intervention (or related USUAL CARE). The incremental costs of an HIV/AIDS intervention are defined as additional costs of that HIV/AIDS intervention relative to costs of USUAL CARE.
The annual number of health outcomes defined in terms of infections and deaths are also projected over the period 2007-2020 for an HIV/AIDS intervention and related USUAL CARE. Total health outcomes of PMTCT and related USUAL CARE are measured in terms of pediatric infections while health outcomes for HAART FOR ADULT and HAART FOR CHILDREN are measured in terms of deaths. Since more infections and deaths are expected with USUAL CARE than with an HIV/AIDS intervention, the incremental effectiveness of an HIV/AIDS intervention is defined as the number of infections averted for PMTCT, and the number of deaths averted for HAART interventions.
The incremental costs and incremental effectiveness of an HIV/AIDS intervention in a given context are used to estimate the incremental CE ratio (ICER) of that HIV/AIDS intervention relative to USUAL CARE (absence of an intervention). The comparison of the CE of an HIV/AIDS intervention across a rural context and an urban context is then done by comparing ICER of that intervention in a rural context to its ICER in an urban context.
The comparison of the CE of an HIV/AIDS intervention across a rural context and an urban context distinguishes the base-case comparison and scenario comparisons. The base-case comparison uses the evidence on the number of patients projected assuming a coverage rate of 97%, base-case values of annual cost estimates and a discount rate of 3%. In the first scenario a decrease in the coverage rate is assumed. In the second scenario, the discount rate is changed to 0% and 7% and the results compared to the results of the base-case analysis. In the third scenario, upper and lower bound estimates of costs are used in the analysis and results compared to the results of the base-case analysis.
The analysis of these scenarios is based on the requirements of CE analysis to check how sensitive the results of the base-case analysis are to the most likely events. The analysis of the effect of a drop in the coverage rate of an HIV/AIDS intervention is due to the potential reduction in the adherence to HIV/AIDS interventions. The long-lasting and widespread antiretroviral resulted in the increase in risky behaviour elsewhere (McGowan et al., 2004) . With widespread antiretroviral therapy in South Africa, risky behaviours such as non-adherence to HIV/AIDS interventions, among others, are expected. Scenario analyses of how the base-case conclusion changes when interventions coverage decrease to 80% in a rural context or in an urban context are conducted. In the first place, the changes in the base-case scenario are analyzed with an assumption of an 80% coverage rate in a rural context, and then an 80% coverage rate in urban context. The analysis of the effect of change in the discount rate is based on the recommendations by an expert panel on CE analysis (Gold et al., 1996) . Alternative discount rates of 0% and 7% are also used to see how the conclusion of the base case analysis is affected. The analysis of the effect of change in the cost-estimates is due to the fact that these costs are expected to be lower in the future and are very uncertain. Scenario analysis is conducted over the base-case scenario by using lower and upper-bound estimates of costs in keeping with high variability and insufficiency in cost-estimates evidence.
Results

Incremental costs
The cost results are presented in Table 2 . These costs are obtained by applying the average annual cost per patient to the number of patient-years using interventions over the period of analysis, as projected by SPMS. As Table 2 shows, the total costs of interventions are less in a rural context than they are in an urban context, and the incremental costs are also less in a rural context than they are in an urban context. Based on the government perspective's costs for example, Table 2 shows that HAART FOR ADULTS results in incremental costs of US$ 1,300,420,075 in a rural context while the corresponding number for an urban context is US$ 2,483,740,496. These results are obvious given that an urban context, as defined in this paper, has a greater number of people living with HIV/AIDS. The comparison is more plausible if the difference in the population of patients across a rural context and an urban context is controlled for. Doing such a control by estimating the incremental costs per 100, 0000 patient-years, Table 2 shows that per 100,000 patient-years, the incremental costs is generally higher in rural contexts, except for PMTCT. The incremental cost per 100,000 patient-years for PMTCT is US$ 10,580,584 in a rural context while it is US$18,041,585 in an urban context, considering costs evaluated from the perspective of government. The last row of Table 2 which shows the incremental costs in a rural context expressed as a percentage of the incremental costs in an urban context for each interventions indicates that indeed, such costs are lower in a rural context than they are in an urban context. The row shows that percentage to be 58% for PMTCT while it is 137% and 103% for HAART FOR ADULTS and HAART FOR CHILDREN.
Incremental effectiveness
After comparing the incremental costs of each HIV/AIDS intervention relative to USUAL CARE across a rural context and an urban context, it is worth also to compare the incremental effectiveness of an HIV/AIDS intervention in a rural context and an urban context. The effectiveness measures used in this comparison are infections and deaths averted by an HIV/AIDS intervention relative to USUAL CARE. Table 3 shows the results.
The results in Table 3 indicate that for each HIV/AIDS intervention, the number of infections (deaths) averted by an HIV/AIDS intervention relative to USUAL CARE is less in a rural context than it is in an urban context. For instance, PMTCT averts 116,866 infections over the period 2007-2020 in a rural context and 193,164 infections in an urban context over the same period. However, this finding needs to be considered bearing in mind that the size of the population of patients in these contexts is different. Since there are fewer patients in an HIV/AIDS intervention in a rural context, fewer infections and deaths averted are expected there. To control for the number of patients as in the analysis of incremental costs, estimates of incremental effectiveness are reported per 100,000 patient-years in each context. Table 4 shows the results.
As Table 4 indicates, modeled HIV/AIDS interventions are less effective in a rural context than they are in an urban context. Table 4 indicates that per 100,000 patient-years, PMTCT prevent less HIV infections in a rural context than it does in an urban context. In fact, the intervention prevents 7, 7400 infections in a rural context while it prevents 88,700 infections in an urban context over the period of analysis. Similarly, HAART FOR ADULTS and HAART FOR CHILDREN prevent fewer deaths in a rural context. Per 100,000 patient-years, HAART for ADULTS prevents 68,700 HIV/AIDS deaths in a rural context while it prevents about 71,600 HIV/AIDS deaths in an urban context. Corresponding statistics of HIV/AIDS deaths averted by HAART FOR CHILDREN are 58,500 (rural) and 61,500. Because less HIV infections and HIV/AIDS deaths are averted in a rural context, the incremental effectiveness in a rural context expressed as percentage of the incremental effectiveness in an urban context is less than 100%.
Cost-effectiveness
In CE analysis however, it is important to analyze the additional costs arising from additional benefits, relative to USUAL CARE, of an HIV/AIDS intervention in each context. The ICER of an HIV/AIDS intervention relative to USUAL CARE is reported in a rural context and an urban context and the ICERs of the same intervention are compared across contexts, in the base-case comparison. Table 5 shows the results.
The results in Table 5 indicate that PMTCT is more cost-effective in a rural context than it is in an urban context. From a government perspective's costs, the ICER of PMTCT in a rural context is US$1,367 per infection averted in a rural context and US$2,034 in an urban context. In terms of relative costeffectiveness, the ICER of PMTCT in a rural context is 67% of its ICER in an urban context. Therefore, PMTCT is more cost-effective in a rural context than it is in an urban context.
HAART FOR ADULTS and HAART FOR CHILDREN are less cost-effective in a rural context than they are in an urban context. Their ICERs are US$ 2,456 and US$ 2,266 respectively per death averted in a rural context while these ICERs are US$1,712 and US$2,070 per death averted in an urban context. In terms of relative cost-effectiveness, the ICERs of HAART FOR ADULTS and HAART FOR CHILDREN in a rural context are 143% and 109% of their respective ICERs in an urban context. This result shows that HAART FOR ADULTS and HAART FOR CHILDREN are relatively less cost-effective in a rural context. Furthermore, the results in Table 5 show the extent to which CE estimates vary across HIV/AIDS interventions. The extent of CE in any context is measured by how far the ICER of an HIV/AIDS intervention in one context expressed as percentage of the ICER of that intervention in another context, is to 100%. The last row of Table 5 shows that the percentage of the ICER of an intervention in a rural context, measured from the perspective of government, relative to the ICER of the same intervention in an urban context varies across modeled interventions. A given intervention would be equally effective in a rural context and an urban context if this percentage is 100%. Since reported percentages of the three interventions are far away from 100% to a different extent, the CE of modeled interventions depends on the context.
The results in Table 6 illustrate that the CE of HIV/AIDS interventions has no specific trend across a rural context and an urban context as some HIV/AIDS interventions are more cost-effective in a rural context, while for others, the opposite is true. The results also show that the extent of CE is different across interventions.
These results are subjected to sensitivity analysis. One of the key issues likely to affect the effectiveness of HIV/AIDS interventions in lifelong HAART therapy is a decrease in treatment adherence. As this decrease would affect the coverage of HIV/AIDS interventions, the paper analyses the effect of a 20% decrease in coverage (due to a possible decrease in adherence) on the results of the base-case comparison. The results are presented in Table 7 A decrease in the adherence by 20% in one context does not affect the result of the base-case estimates in another context but only estimates in the context in which the decrease takes place. For instance, a decrease in adherence in a rural context by 20% does not affect the ICER of PMTCT in an urban context. The ICER of PMTCT in an urban context remains equal to the ICER of the base-case comparison, that is, US$ 2034. When there is a decrease in adherence in a rural context by 20% however, the ICER of HIV/AIDS interventions in a rural context increases. For instance, the ICER of PMTCT increases from US$ 1367 to US$1417. An implication of this result is that effectiveness of modeled HIV/AIDS interventions decrease more than the decrease in the cost as a result of a reduction in the coverage by 20%.
Similarly, the decrease in adherence by 20% in urban contexts does not affect the results of the base-case comparison in a rural context. However, this decrease in adherence increases the ICER of HIV/AIDS interventions in an urban context. Table 7 shows that the ICER of PMTCT in an urban context, for instance, increases from US$2,034 to US$ 2,101. Again, this observation signifies that, as a result of the decrease in adherence by 20% in a given context, the decrease in the effectiveness is more than the decrease in the costs. However, even though the decrease in the adherence affects the CE of an intervention in a context in which the decrease takes place, it does not affect the comparability of CE of HIV/AIDS interventions across contexts. Therefore the results of the base-case comparison are robust to the change in the adherence.
The discount rates used have been considered as factors influencing the CE results. Consequently, it was recommended (Gold et al., 1996) to see how the conclusions of the base-case comparison change with different discount rates. To this end, CE results of the base-case comparison were reproduced using different discount rates. Table 8 shows the ICER of HIV/AIDS interventions under alternative discount rates. The Table shows as expected, that the ICERs of HIV/AIDS interventions decrease as the discount rates increase. The results show for example that with a discount rate of 3%, the ICER of PMTCT of US$1,367 (measured from the government's perspective) in a rural context changes to US$1,089 with a discount rate of 7%. The same patterns in the change of ICER are observed in an urban context. While these changes are observed for all modeled interventions, they do not change the base-case conclusion.
Finally, the insufficiency of cost data evidence required a scenario analysis of what would happen to the base-case conclusions when the lower and upper bound estimates of costs were used. The results in Table 9 show that the use of lower and upper bound cost estimates changes some of the conclusions in the base-case analysis. For instance, in the base-case comparison, PMTCT was more cost-effective in a rural context than it was in an urban context. While the intervention remains more cost-effective in a rural context with the use of lower bound cost estimates, the opposite is true when upper bound cost estimates are used. Table 9 shows that with upper bound estimates of costs, the ICER of PMTCT in a rural context becomes US$2,815 per infection averted while it is US$ 1,850 per infection averted in an urban context. This result makes PMTCT more cost-effective in an urban context and this conclusion is different from the conclusion in the base-case comparison. The change in the CE comparability of PMTCT across a rural context and an urban context as a result of a change in cost estimates applies to other modeled interventions. HAART FOR ADULTS which was more cost-effective in an urban context than in rural context becomes less cost-effective when lower bound cost estimates are used as shown in Table  9 . As the results in the latter Table change many of the conclusions reached by the base-case comparison, the results are not robust to a change in estimates of cost.
Discussion of the results.
This paper set out to find out whether the CE estimates of HIV/AIDS interventions changes from a rural context to an urban context in South Africa. Estimates obtained through modeling with Spectrum Policy Modeling System, which allowed the interaction between HIV/AIDS interventions and these contexts to be taken into account, revealed that the CE of an HIV/AIDS intervention indeed depends on the context of its implementation. Briefly, the paper found that a given HIV/AIDS intervention results in different CE estimates depending on whether it is implemented in a rural context or an urban context. In particular, the paper found that the ICER of PMTCT in a rural context expressed as a percentage of its ICER in the urban context is 67%. In contrast, the ICERs of HAART FOR ADULTS and HAART FOR CHILDREN in a rural context are 143% and 109% of the ICERs of the same interventions in an urban context.
With the ICER of an HIV/AIDS intervention defined as additional costs per additional health outcomes of that intervention relative to USUAL CARE, the lower the ICER the more the CE of that HIV/AIDS intervention. Therefore, the percentages reported above indicate that HIV/AIDS interventions are not equally cost-effective across socio-economic contexts. For an HIV/AIDS intervention would be equally cost-effective across contexts if its ICER in one context as a percentage of its ICER in another context is 100%. The results have shown that this is not the case. The percentage is less that 100% for PMTCT, suggesting that the latter intervention is more cost-effective in a rural context than it is in an urban context, and more that than 100% for HAART FOR ADULTS and HAART FOR CHILDREN, indicating that the latter interventions are more cost-effective in an urban context than they are in a rural context. Not only is CE of an HIV/AIDS intervention different in rural and urban contexts, but also the extent of the difference varies across modeled HIV/AIDS interventions. Measuring the extent of the relative CE of an HIV/AIDS intervention across contexts in terms of how far the relative ICER is to 100%, the results indicate, for instance, that HAART FOR ADULTS has the greatest extent of CE in ur-ban context with its ICER in a rural context being 143% of its ICER in an urban context.
Interpreting the meaning of these results requires reverting back to the methodology used in this analysis. After controlling for the difference in the sizes of patients, the costs and effectiveness results should have been the same across contexts. The fact that the results are not the same can be explained by the influence of the interaction between HIV/AIDS interventions and contextual and individual factors. Theory indicates that those individual risk behaviours can be shaped by the contexts in which people live (see for instance among many others, Marmot & Wilkinson, 2005; Phillipson and Poster, 1993; Ajzen, 1991) . Since these factors prevail to a different extent and in complex patterns in modeled contexts, and a standard HIV/AIDS intervention does not necessarily target all these factors, the CE of an HIV/AIDS intervention across a rural context and an urban context is doomed to be different.
These results have some precedents in the literature. Veguet and Wash (2012) compared the CE of microbicides in South Africa and the US. The results over one year for a hypothetical population of patients showed that the cost and effectiveness in the US and South Africa were different. Over one year, it was estimated that the intervention prevents 1,908 new infections in South Africa, and 21 new infections in the US. In South Africa, the saving of the intervention was estimated at US$6,712 per infection averted while no saving was reported in the US. A related study by Dowdy et al. (2006) compared the CE of nitrile female condom across South Africa and Brazil, which are comparable in in terms of socio-economic status and risk behaviours. The results, over a period of three years on 1,000 hypothetical patients, were that expanding female condom use to 10% of the adult females would avert 604 infections at US$20,683 in Brazil, while in South Africa, 9,577 infections could be averted at US$985 per infection averted. While these studies constitute an important contribution to the literature, they aimed to inform international policy makers rather than South African ones. This paper has contributed to the literature by providing South African policy makers with estimates of how CE of major HIV/AIDS interventions compare in a rural context and an urban context. Different CE across a rural context and an urban context for a given HIV/AIDS intervention reveals to policy makers efficiency opportunities in resource allocation. South African policy makers have been implementing HIV/AIDS interventions on the basis of other factors and regardless of how HIV/AIDS are cost-effective in different socio-economic contexts. It is therefore time for the policy maker to start considering socioeconomic contexts when allocating resources in HIV/AIDS interventions.
Finally, it is worth to caution that the findings of this study need to be understood in the context of the evidence used. While scenario analysis on the discount rates and the coverage of HIV/AIDS interventions did not seem to reveal a change in the conclusions of the base-case analysis, the conclusions of the latter analysis were very sensitive to the cost assumptions. If the cost estimates which underpin the modeled interventions are inadequate, the results are likely to be inaccurate. The deficiency in cost-estimates calls for more cost analysis studies for health care interventions in general and HIV/AIDS interventions in particular, if policy on HIV/AIDS interventions is to be founded on solid evidence. Previous studies such as Creese et al. (2002) and Walker (2003) also pointed to this need in developing countries. Table 5 reflects the value of the ICER in a rural context as percentage of the ICER in an urban context for a given HIV/AIDS intervention. 
